Media Contacts Sabrina Zappia Catania (Italy) – 9 June 2021 – SIFI, a leading international ophthalmic company focused on the development and commercialization of innovative therapeutic solutions for patients with ophthalmic condition...

> leggi

SIFI expands its presence in eastern Europe and northern Asia entering into a multi-year commercial agreement with Bausch Health Russia Catania, Italy - May 17, 2021 – SIFI, a leading international ophthalmic company, announces it has entere...

> leggi

ProGIFT is a 3 arms, multicenter, randomized, double-masked clinical trial in Italy. Catania (Italy) - 27 April 2021 - SIFI announced today the enrollment of the first patients in the ProGIFT trial (NCT04645446), which aims at evaluating the safet...

> leggi

Shanghai, China and Catania, Italy - March 31, 2021. AffaMed Therapeutics (“AffaMed”), a global clinical-stage biopharmaceutical company dedicated to addressing critical unmet patient need in ophthalmic, neurological and psychiatric disor...

> leggi

Leading ophthalmic products, including NETILDEX®, NETIRA® and EYESTIL® will soon be marketed directly by SIFI Ilaç. Catania, Italy - March 22, 2021 – SIFI, a leading ophthalmic company, is pleased to announce that the Turk...

> leggi